Blocking unwanted macrophage phagocytosis by triggering sialoadhesin to enhance tumor derived apopto

Development of gene-modified cellular immunotherapies against immunological "cold" cancers

Diagnostic examinations of an autologous tumor-immune xenograft as a test platform for immunotherapeutic intervention with non-small cell lung cancer

Gene-Environment iNteractions in the pathogenesis of Tobacco smoking-induced Lung diseases (GENT-Lung)

HIGH-THROUGHPUT, HIGH-SENSITIVITY AND COST-EFFECTIVE MONITORING OF INNATE AND ADAPTIVE IMMUNE RESPONSES AT SINGLE CELL LEVEL

Immunopeptidomics-based Development of Next-Generation Bacterial mRNA Vaccines

Improving outcome of immune checkpoint blockade in lung cancer by combination with a tumor mutanome-targeted dendritic cell vaccine

IP strenghtening for MIDRIX, a unique manufacturing process for dendritic cell immunotherapy in solid cancers

MesoBreath 3: Analysis of Volatile Organic Compounds from mesothelioma cells and pleural effusions with gas chromatography-mass spectrometry (GC_MS) and ion mobility spectrometry (IMS)

Oxygen-sensing by professional antigen presenting cells in the tumor micro-environment and its impact on adaptive anti-tumor immunity.

Proteomics-derived epitopes for dramatically improved anticancer and antibacterial vaccine development

REACTION: A modular mRNA-encoded artificial receptor for focused re-ignition of anti-cancer immune responses

REACTION: A modular mRNA-encoded artificial receptor for focused re-ignition of anti-cancer immune responses

Reprogramming of tumor-associated dendritic cells on microRNA level as a novel immune escape mechanism in cancer

SparXells™ : Enabling Next-Generation Dendritic Cell Therapy in Lung cancer and Beyond

TARgeted Mrna re-engineering for enhanced Antibody and Cellular immunity (TARMAC)

Use of an integrative classification system and next-generation sequencing strategies for gene identification in common variable immunodeficiency disorder (CVID)

An autologous tumor-immune system humanized mouse model for the development of dendritic cell-based vaccines in lung cancer

A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapies

Automatic bench-top cell sorter with biosafety hood for use in a level 3 class biosafety laboratory

BioGelator for local immunotherapy

Development of a non-invasive test to predict immunotherapy response in lung cancer patients

Engineered microparticulate cancer vaccines based on tumour-specific antigens formulated with immune-modulating polymers

FullPicture: Combining Spectral Flow Cytometry with High-Speed Cell Imaging to enable comprehensive profiling of plant and animal cells and their components in real time.

Gene-Environment iNteractions in the pathogenesis of Tobacco smoking-induced Lung diseases (GENT-Lung)

Immunomonitoring of patients with non-small cell lung carcinoma treated with a tumor mutanome-targeted dendritic cell vaccine

Improving outcome of immune checkpoint blockade in lung cancer by combination with a tumor mutanome-targeted dendritic cell vaccine

Improving outcome of immune checkpoint blockade in lung cancer by combination with a tumor mutanome-targeted dendritic cell vaccine

Longitudinal imaging of cellular dynamics with a biostation IM-Q (microscope with sensitive CCD camera and integrated incubator)

Non-invasive prediction of immune-therapy response in lung cancer patients (NIPIT)

Research Equipment: BD LSRFortessa TM flowcytometer

Use of an integrative classification system and next-generation sequencing strategies for gene identification in common variable immunodeficiency disorder (CVID).

An integrated strategy for preclinical development of improved vaccines against dendritrische cell lung cancer